Even as FIIs consider valuations in the secondary market high, they remain upbeat on India's market narrative, compelling them to seize every opportunity, say experts.

Dr Agarwal's Healthcare IPO price band is set at ₹382 to ₹402 per equity share. The subscription date is from January 29 to January 31.

Ascentage Pharma said on Thursday it aims to raise $126.4 million in an initial public offering in the United States, becoming the first sizeable Chinese firm to seek a listing in the U.S. this year.

(Reuters) -Venture Global LNG has raised $1.75 billion after pricing its U.S. initial public offering within range, the ...

Following a filing revealing its intent to go public in the US on 6 January, artificial pancreas maker Beta Bionics has now set its financial goalposts, aiming to raise $114.4m from the initial public ...

Ribbon Acquisition Corp , a special purpose acquisition company (SPAC), has successfully completed its initial public offering (IPO), raising $52.2 million in total proceeds. The company, which trades ...

This edition of the Bermuda Public Companies Update summarises significant transactions involving Bermuda companies listed on the New York ...

Aardvark said it applied to list on the Nasdaq Global Market under the symbol AARD. The company didn't give an expected size for its IPO, nor did it offer an expected price range. Morgan Stanley, B of ...

Shares surged through the $40 level as the stock gained another 20%. Nano Nuclear shares are now trading 75& higher in 2025 ...

Rashaun Williams, Atlanta Falcons limited partner and venture capitalist, joined "Closing Bell" on CNBC to discuss his investment strategy and his outlook on the IPO market as 2025 ...

A global biopharma with a U.S. headquarters in Montgomery County is gearing up to go public on a U.S. exchange.

Skyline Builders Group Holding Limited (NASDAQ: SKBL), a Hong Kong-based public works contractor, launched its initial public ...